Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients.
Tanabe
K
K
Department of Urology, Kidney Center, Tokyo Women's Medical College, Japan.
Kitani
R
R
Takahashi
K
K
Tokumoto
T
T
Ishikawa
N
N
Oshima
T
T
Kanematsu
A
A
Fuchinoue
S
S
Yagisawa
T
T
Ota
K
K
Toma
H
H
D000328:Adult; D002423:Cause of Death; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D015490:HTLV-I Infections / Q000150:complications* / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000601:surgery*; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D013997:Time Factors
D007166:Immunosuppressive Agents